Month: <span>April 2018</span>

Home / 2018 / April
Post

Medical doctors remain trapped in their substance-use disorders

Fear of dismissal or of losing their authorization keeps medical doctors trapped in their substance use disorders, and instead of seeking help they attempt self-treatment. This is shown by a new study from Aarhus University. It is just as difficult for the individual medical doctor to ask for help with his or her substance use...

Post

Drug combination targeting HSP90 and BRAF is safe and effective in advanced melanoma

XL888 Plus vemurafenib results in manageable toxicity and durable responses in advanced and metastatic melanoma patients TAMPA, Fla. – Patients with advanced or metastatic melanoma have been able to live longer cancer-free lives because of several new therapies approved over the last decade, such as BRAF and MEK inhibitors. However, despite the success of these...

Post

UPV/EHU researchers account for the complex symptoms of Angelman syndrome

The disease, which causes problems in intellectual and motor development, affects one in every 15,000 newborns The group, led by the Ikerbasque professor Ugo Mayor of the UPV/EHU’s Department of Biochemistry and Molecular Biology, has just published in the journal Human Molecular Genetics an explanation of the mechanisms affected by Angelman syndrome. Thanks to an...

Post

Chip-based blood test for multiple myeloma could make bone biopsies a relic of the past

IMAGE: A NEW UNIVERSITY OF KANSAS RESEARCH EFFORT FEATURED IN THE CURRENT EDITION OF INTEGRATIVE BIOLOGY HAS RESULTED IN A LOW-COST, RELIABLE BLOOD TEST THAT USES A SMALL PLASTIC CHIP ABOUT LAWRENCE — The diagnosis and treatment of multiple myeloma, a cancer affecting plasma cells, traditionally forces patients to suffer through a painful bone biopsy. During...

Post

GLUT5 fluorescent probe fingerprints cancer cells

Determining the presence of cancer, as well as its type and malignancy, is a stressful process for patients that can take up to two weeks to get a diagnosis. With a new bit of technology–a sugar-transporting biosensor–researchers at Michigan Technological University hope to reduce that timeframe down to minutes.  IMAGE: THE MANCOU MULTICOLORED FLUORESCENT PROBE GLOWS...

Post

Google Augmented Reality Microscope to Help Automate Pathology

Google has developed an “Augmented Reality Microscope” that allows various deep learning algorithms to be tried on the images that it captures and for the results to be immediately seen in the microscope’s field of view. Moreover, the same technology can be integrated into existing clinical microscopes. This can really help the people working on...

Post

Psoriasis treated with compound derived from immune cells

A compound derived from immune cells treats psoriasis in mice and holds promise for other autoimmune diseases, according to a new study from Washington University School of Medicine in St. Louis. The compound suppresses an inflammatory pathway that is overactive in many autoimmune diseases, suggesting that it may be effective against multiple sclerosis, rheumatoid arthritis, lupus and...

Post

An artificial mole as an early warning system

As soon as the calcium level exceeds a particular threshold over a longer period of time, an implant inserted under the skin triggers the production of melanin. This causes a mole to form. Alongside cardiovascular disease, cancer has become the top cause of death in industrialized countries. Many of those affected are diagnosed only after...

Post

Prostate cancer breakthrough: Patients could be treated with drugs currently used for breast, ovarian and skin cancer, study reveals

Scientists have discovered 80 proteins which trigger prostate cancer  Revelations mean drugs used on breast, ovarian and skin cancer could be used Could be life-saving for one in seven men who die within a decade of diagnosis  Thousands of men’s lives could be saved after a world first study found new ways to tackle prostate...